Specifically, Kaplan–Meier survival analyses indicated that CRC patients with high HOXB-AS3 peptide expression had a 1.6-fold increase in mean overall survival time compared to those with low expression, suggesting that high expression of the HOXB-AS3 peptide correlates with reduced CRC-related mortalities [62]. Here, PDS5B is linked to colorectal carcinoma.